— Know what they know.
Not Investment Advice

TSVT NASDAQ

2seventy bio, Inc.
1W: +0.0% 1M: +0.8% 3M: +104.1% 1Y: +11.6% 3Y: -64.3%
$5.00
Last traded 2025-05-12 — delisted
NASDAQ · Healthcare · Biotechnology · $266.1M mcap · 43M float · 3.42% daily turnover · Short 55% of daily vol

Balance Sheet Trends

Total Assets
$480M -15.2% ▼
5Y CAGR: +8.8%
Total Liabilities
$269M -13.4% ▼
5Y CAGR: -0.2%
Shareholders Equity
$211M -17.4% ▼
5Y CAGR: +37.0%
Cash & Investments
$175M -19.5% ▼
Total Debt
$244M -5.0% ▼
5Y CAGR: +12.8%
Net Debt
$172M -5.1% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2020FY2021FY2022FY2023FY2024
— Assets —
Cash-$128M$130M$71M$75M$71M
Short-Term Investments$0$135M$195M$142M$104M
Cash & ST Investments-$128M$362M$266M$217M$175M
Net Receivables$11M$17M$21M$13M$8M
Inventory$128M-$114M$14M$0$0
Other Current Assets$0$0$0$0$0
Total Current Assets$25M$292M$301M$238M$187M
Property, Plant & Equip.$260M$310M$297M$278M$238M
Goodwill & Intangibles$19M$22M$19M$7M$6M
Long-Term Investments$0$97M$1M$5M$9M
Other Non-Current Assets$8M$39M$38M$38M$39M
Total Non-Current Assets$288M$468M$356M$328M$292M
Total Assets$313M$760M$657M$565M$480M
— Liabilities —
Accounts Payable$7M$6M$7M$6M$1M
Short-Term Debt$15M$10M$11M$0$0
Deferred Revenue$820K$5M$3M$15M$0
Other Current Liabilities$19M$46M$32M$7M$7M
Total Current Liabilities$76M$98M$80M$60M$40M
Long-Term Debt$112M$272M$0$0$0
Other Non-Current Liab.-$62M-$269M$2M$2M$1M
Total Non-Current Liabilities$162M$301M$266M$250M$229M
Total Liabilities$238M$400M$346M$310M$269M
— Equity —
Common Stock$75M$2K$4K$5K$5K
Retained Earnings$0-$39M-$294M-$511M-$568M
Accumulated OCI$75M-$712K-$3M-$204K$89K
Total Stockholders Equity$75M$360M$310M$255M$211M
Total Liabilities & Equity$313M$760M$657M$565M$480M
— Key Metrics —
Total Debt$128M$282M$270M$257M$244M
Net Debt$255M$152M$199M$182M$172M
Total Investments$0$232M$197M$147M$112M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms